Xcel Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,354
Closed -$370K 112
2023
Q2
$370K Sell
5,354
-84
-2% -$5.98K 0.12% 103
2023
Q1
$404K Sell
5,438
-4
-0.1% -$335 0.14% 95
2022
Q4
$507K Hold
5,442
0.2% 79
2022
Q3
$519K Hold
5,442
0.19% 77
2022
Q2
$504K Sell
5,442
-17
-0.3% -$1.66K 0.18% 77
2022
Q1
$553K Sell
5,459
-10,550
-66% -$1.11M 0.15% 90
2021
Q4
$1.65M Sell
16,009
-1,496
-9% -$138K 0.42% 59
2021
Q3
$1.49M Sell
17,505
-4,250
-20% -$356K 0.43% 62
2021
Q2
$1.81M Sell
21,755
-7,875
-27% -$645K 0.55% 50
2021
Q1
$2.23M Sell
29,630
-2,510
-8% -$183K 0.8% 36
2020
Q4
$2.19M Buy
32,140
+222
+0.7% +$14.4K 0.95% 34
2020
Q3
$1.86M Buy
31,918
+5,725
+22% +$356K 0.96% 33
2020
Q2
$1.7M Sell
26,193
-2,650
-9% -$167K 1.06% 30
2020
Q1
$1.71M Buy
28,843
+9,030
+46% +$603K 1.54% 23
2019
Q4
$1.47M Buy
19,813
+290
+1% +$20.4K 1.22% 26
2019
Q3
$1.23M Sell
19,523
-1,985
-9% -$118K 1.14% 28
2019
Q2
$1.17M Buy
21,508
+3,464
+19% +$187K 1.15% 29
2019
Q1
$973K Buy
+18,044
New +$1.11M 1% 31

Other funds holding CVS

Xcel Wealth Management's CVS Position: Q3 2023 in Review

Xcel Wealth Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 5,354 shares — an estimated $370K sold.

Xcel Wealth Management first reported a position in CVS in Q1 2019 and held it in 18 quarters. The position peaked at $2.23M in Q1 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Xcel Wealth Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Xcel Wealth Management sold 5,354 CVS Health shares in Q3 2023, an estimated $370K.
  • Xcel Wealth Management first reported a position in CVS Health in Q1 2019 and held it in 18 quarters.
  • Xcel Wealth Management's CVS Health position peaked at $2.23M in Q1 2021.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Xcel Wealth Management's 13F filing for Q3 2023, filed 17 Oct 2023.